stockrowAxsome Therapeutics, Inc.
AXSM Healthcare Biotechnology
Axsome Therapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $638.5 million, up 65.5% from fiscal 2024.
- Revenue
- +51.9%
- EPS
- +73.9%
- Free cash flow
- −1,078.3%
- Total debt
- +4.04%
Quarter to September 2026, against a year earlier
Follow AXSM
Alert me
Axsome Therapeutics, Inc. (AXSM) Shares outstanding
Axsome Therapeutics, Inc.'s shares outstanding at the end of fiscal 2025 was $49.7M, unchanged from fiscal 2024. At the end of the quarter to 30 September 2026 it was $52.4M. Over the past ten years it has ranged from $11.9M (fiscal 2015) to $49.7M (fiscal 2025) — the current reading is the highest in ten years. Axsome Therapeutics, Inc. ranks 286th of 600 Biotechnology companies by shares outstanding.
Shares outstanding, annual
Embed this chart
Annual newest first
| Period | Shares outstanding | Change |
|---|---|---|
| FY2025 | $49.7M | 3.83% |
| FY2024 | $47.9M | 5.48% |
| FY2023 | $45.4M | 11.73% |
| FY2022 | $40.7M | 8.07% |
| FY2021 | $37.6M | 1.11% |
| FY2020 | $37.2M | 9.37% |
| FY2019 | $34.0M | 26.55% |
| FY2018 | $26.9M | 18.09% |
| FY2017 | $22.8M | 18.87% |
| FY2016 | $19.2M | 60.32% |
Quarterly newest first
| Period | Shares outstanding | Change |
|---|---|---|
| Sep 2026 | $52.4M | 1.25% |
| Jun 2026 | $51.8M | 1.18% |
| Mar 2026 | $51.2M | 2.92% |
| Dec 2025 | $49.7M | (0.55%) |
| 43 more quarters | Free account |
Against its own ten years
Shares outstanding against peers
| Company | Shares outstanding |
|---|---|
| IONS Ionis Pharmaceuticals, Inc. compare | $165.4M |
| ABVX Abivax SA Sponsored ADR compare | $79.6M |
| RYTM Rhythm Pharmaceuticals, Inc. compare | $69.0M |
| MIRM Mirum Pharmaceuticals, Inc. compare | $66.1M |
| ORKA Oruka Therapeutics, Inc. compare | $62.9M |
| AXSM Axsome Therapeutics, Inc. | $52.4M |
| BLTE Belite Bio, Inc. Sponsored ADR compare | $40.2M |
| PRAX Praxis Precision Medicines, Inc. compare | $29.1M |
| LGND Ligand Pharmaceuticals Incorporated compare | $20.0M |
What Shares outstanding is
Shares (Diluted, Weighted) tells an investor how many shares a company’s earnings are spread across once potential new shares are counted.
Reported line item
More on AXSM
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Book value per share
- Revenue growth
- Altman Z-score
- Beneish M-score
- The full statement